<DOC>
	<DOCNO>NCT01512095</DOCNO>
	<brief_summary>This trial conduct Europe United States America ( USA ) . The aim trial examine bioequivalence ( assessment expect biological equivalence two pharmaceutical drug product identical active ingredient ) Norditropin速 versus Nutropin AQ速 healthy adult volunteer .</brief_summary>
	<brief_title>Bioequivalence Two Products ( Norditropin速 Versus Nutropin AQ速 ) Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>No previous exposure recombinant human GH ( growth hormone ) IGFI ( insulinlike growth factorI ) Body mass index ( BMI ) 18.027.0 kg/m^2 ( inclusive ) Considered generally healthy upon completion medical history , physical examination , vital sign , screen laboratory result , electrocardiogram ( ECG ) , judge Investigator The receipt investigational medicinal product within 1 month prior trial Current previous treatment recombinant human growth hormone IGFI Female childbearing potential pregnant , breastfeed intend become pregnant use adequate contraceptive method ( adequate contraceptive measure require local law ) duration trial Known presence history malignancy Diabetes mellitus Use pharmacologic dos glucocorticoid Use anabolic steroid History drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>